ライフサイエンスコーパス: long-chain

1 ociated with linking inorganic elements into long chains.

2 ngth, with Fermi level crossing observed for long chains.

3 sed were unable to optimally search over all long chains.

4 everity of neuropathy and the levels of very-long-chain 1-deoxyceramides such as C24 (P < 0.05), with

5 sm that enables Hydra to specifically modify long-chain 3-oxo-homoserine lactones into their 3-hydrox

6 lyunsaturated fatty acids (PUFAs) into their long-chain active form.

7 86, Subfamily A, Polypeptide2 (CYP86A2) and Long Chain Acyl Synthetase2 (LACS2), which catalyze two

8 mice lacking the fatty acid oxidation enzyme long-chain acyl-CoA dehydrogenase (LCAD).

9 mice decreased acetylation of mitochondrial long-chain acyl-CoA dehydrogenase, a known SIRT3 deacety

10 The capacity of ACOT7 to hydrolyze long-chain acyl-CoA esters suggests potential roles in b

11 ACBP binds very-long-chain acyl-CoA esters, which is required for its ab

12 Long-chain acyl-CoA synthetase 1 (ACSL1) plays a key rol

13 f cardiac lipotoxicity overexpressing ACSL1 (long-chain acyl-CoA synthetase 1) in cardiomyocytes, we

14 Long-chain acyl-CoA synthetase 6 (ACSL6) mRNA is present

15 KEY POINTS: Long-chain acyl-CoA synthetase 6 (ACSL6) mRNA is present

16 This study revealed a central role of the long-chain acyl-CoA synthetase LCS2 in the production of

17 s a prodrug that requires activation by very long-chain acyl-CoA synthetase-1 (ACSVL1) to modulate bo

18 Long-chain acyl-CoA synthetases (ACSL 1 to 6) are key en

19 ABSTRACT: Long-chain acyl-CoA synthetases (ACSL 1 to 6) are key en

20 Long-chain acyl-CoA synthetases (ACSLs) are key host-cel

21 Recent findings indicate that inhibition of long-chain acyl-CoA synthetases with triacsin C, a fatty

22 KO) mice have lower ECHA activity, increased long-chain acyl-CoAs, and decreased ATP in the heart und

23 hA6 is non-catalytic yet essential and binds long-chain acyl-CoAs.

24 nfrared microspectroscopy, the cutin mutants long-chain acyl-coenzyme A synthetase2 (lacs2), permeabl

25 The increases in long-chain acylarnitine metabolites and short-chain dica

26 dation disorders and cardiac ischemia) where long-chain acylcarnitine accumulation is evident.

27 odel in which oxy-Mb is a novel regulator of long-chain acylcarnitine and fatty acid pools in Mb-rich

28 Higher long-chain acylcarnitine concentrations, lipid transport

29 P = .01, .04, and .05, respectively), and 1 long-chain acylcarnitine metabolite (palmitoyl carnitine

30 In chronic HF patients, circulating long-chain acylcarnitine metabolite levels were independ

31 increased glycolysis and an accumulation of long chain acylcarnitines.

32 ted metabolomics studies showed that several long-chain acylcarnitines (10:1, 12:0, 12:2, 18:1, and 1

33 evels of free fatty acid, ketone bodies, and long-chain acylcarnitines and 2) cardiac triglyceride ac

34 Long-chain acylcarnitines co-localize with pulmonary sur

35 Circulating free FAs and long-chain acylcarnitines were elevated in PAH patients

36 Human RV long-chain FAs were increased and long-chain acylcarnitines were markedly reduced in PAH v

37 eline concentrations of short-, medium-, and long-chain acylcarnitines who were randomly assigned to

38 Of these, factor 5 (composed of long-chain acylcarnitines) was associated with increased

39 of myocardial lipid intermediates, including long-chain acylcarnitines, the primary subset of energet

40 ell established activities of the sirtuins, "long chain" acyllysine modifications were also shown to

41 ganic ice-nucleating surfaces, monolayers of long chain alcohols are particularly effective, while mo

42 Direct analysis and identification of long chain aliphatic primary diamine Duomeen O (n-oleyl-

43 Their long-chain aliphatic alcohols and monoglycerides composi

44 ble cavitands in the Staudinger reduction of long-chain aliphatic diazides (C8 , C10 , and C12 ).

45 Examples include long-chain alkanes, halogenated aromatics, and cyclic vo

46 Affimer characterization was achieved using long-chained alkanethiol linkers coupled with oligoethyl

47 Perfluorinated long chain alkyl amides aggregate in liquid ammonia with

48 The corresponding perfluorinated long chain alkyl carboxylates form ion pairs in liquid a

49 In the resulting structures, long chain alkyl groups (C12 and C14) and phosphopanteth

50 construction of imide and amide bonds with a long-chain alkyl group is an attractive feature of this

51 from serum or water on glass substrates via long-chain alkyls and tagged with reporter gold nanopart

52 (II) precursor under H2 in the presence of a long-chain amine and a long-chain carboxylic acid.

53 hat TmELO1 and TmELO2 function to synthesize long chain and very long chain fatty acids.

54 we studied structural features of the novel long chains and analyzed the assembly of these into tetr

55 s exhibit enhanced AO tolerance and enhanced long chain AO incorporation.

56 as not compensated by enhanced generation of long-chain apocarotenals but resulted in higher levels o

57 tpI-4 protein may facilitate the transfer of long-chain as well as very-long-chain fatty acids into t

58 evealed that like the alpha3 chain the novel long chains assemble to homotetramers that are incorpora

59 mutant to PHS, suggesting that VPA increases long chain base levels.

60 atty acyl (C18) ceramide, cause elevation of long-chain base (LCB) substrates and decrease in C18 cer

61 ough an additional hydroxyl in the sphingoid long-chain base slightly destabilized the ceramide's int

62 sferase inhibition due to impaired sphingoid long-chain base synthesis.

63 en coexpressed with Arabidopsis SPT subunits long-chain base1 (LCB1) and LCB2 and the small subunit o

64 MenA inhibiting, long chain-based compounds were designed, synthesized an

65 biosynthetic precursors, including sphingoid long chain bases and ceramides, have important signaling

66 levels of RSB1, which encodes an exporter of long chain bases dihydrosphingosine (DHS) and phytosphin

67 long-chain fatty acids (VLCFA) and sphingoid long-chain bases, which are amide linked to form ceramid

68 in the presence of a long-chain amine and a long-chain carboxylic acid.

69 activity, this enzyme can use cellobiose and long-chain cellodextrins with a degree of polymerization

70 th a significant reduction in long- and very-long-chain ceramide levels.

71 Pharmacological analysis demonstrated that long-chain ceramide regenerated from C6-ceramide through

72 showed strong specificity, interacting with long chain chitooligosaccharides but not with maltooligo

73 through by general diffusion while allowing long chain chitooligosaccharides to pass through by a fa

74 Long-chain chitooligosaccharides are fungal microbe-asso

75 the complex mixture of short-, median-, and long-chain CPs (SCCPs, MCCPs, and LCCPs) in Australian s

76 in electrophysiological responses to several long-chained cuticular hydrocarbons.

77 s evaluation of the properties of SIRT2 as a long chain deacylase enzyme.

78 h as octylglucoside are more denaturing than long chain detergents such as dodecylmaltoside.

79 rt-chain congeners, polycondensates based on long-chain difunctional monomers are often dominated by

80 clusively for the dominating Dols, while for long-chain Dols, the relative input of the MEP and MVA p

81 ergent sites of synthesis for dominating and long-chain Dols.

82 However, amylopectin long chains (DP 13-26), average chain length and thermal

83 anisms underlying protection include reduced long chain FA uptake, shifts in FA distribution (lipidom

84 0) SM in cancer cells and became enriched in long-chain FA (C16:0) SM.

85 y acid receptor (FFAR) 1 (FFA1), which binds long-chain FA (LCFA), and SCFA receptors FFA2 and FFA3 w

86 nd are capable of intracellular transport of long-chain FA.

87 e first time, higher bioaccessibility of the long-chain FAs than the short- and medium-chain FAs was

88 Human RV long-chain FAs were increased and long-chain acylcarniti

89 The elongases of very long chain fatty acid (ELOVL or ELO) are essential in th

90 provide insight into the regulation of very long chain fatty acid (VLCFA) biosynthesis in Brassica n

91 omal transmembrane protein required for very long chain fatty acid (VLCFA) metabolism.

92 ter interface in presence of model saturated long chain fatty acid and alcohol surfactants, nonanoic

93 presence of protective mechanisms toward the long chain fatty acid effects in bacteria belonging to C

94 etwork is necessary for ileal propionate and long chain fatty acid sensing to regulate glucose homeos

95 longases that catalyze the synthesis of very long chain fatty acids (C24 to C26) required for ceramid

96 recyclable, due to incomplete degradation of long chain fatty acids (LCFA) released during lipids hyd

97 Long chain fatty acids (LCFA) serve as energy sources, c

98 herapeutic functions of HSA is the amount of long chain fatty acids (LCFAs) bound to HSA.

99 anaerobic digestion metatranscriptome after long chain fatty acids (oleate) exposure.

100 he metabolic regulator factors elongation of long chain fatty acids 7 (Elovl7) and cytochrome B5 redu

101 scribe the structure of CD36 in complex with long chain fatty acids and a CD36-binding PfEMP1 protein

102 Mycolic acids are unique long chain fatty acids found in the lipid-rich cell wall

103 dratases are required for elongation of very long chain fatty acids, and HACD1 has a role in early my

104 We found very long chain fatty acids, medium chain acylcarnitines, and

105 oprotein particles and facilitates uptake of long chain fatty acids.

106 sis and increasing import of cholesterol and long chain fatty acids.

107 2 function to synthesize long chain and very long chain fatty acids.

108 Long chain fatty alcohols (>C12) are mainly used in surf

109 We showed that NLMs lost saturated very-long-chain fatty acid (FA; C24:0) SM in cancer cells and

110 chefflera elegantissima) contained only very-long-chain fatty acid (VLCFA) derivatives such as alcoho

111 which catalyze two successive steps in very-long-chain fatty acid (VLCFA) synthesis.

112 ids that are assumed to mimic the endogenous long-chain fatty acid agonists.

113 ons with apolar molecules; both hexane and a long-chain fatty acid belonging to the quorum-sensing sy

114 Medium- and long-chain fatty acid levels were quantified in serum fr

115 growth in mucus and on plates containing the long-chain fatty acid oleate as the sole carbon source.

116 that ACAD9 knockout in HEK293 cells affected long-chain fatty acid oxidation along with Cl, both of w

117 loss of an obligate enzyme in mitochondrial long-chain fatty acid oxidation, carnitine palmitoyltran

118 its translocation to the plasma membrane and long-chain fatty acid uptake.

119 showed an enrichment of 2-hydroxylated very-long-chain fatty acid-containing GIPCs and polyglycosyla

120 Resolution is mediated in part by long-chain fatty acid-derived lipid mediators called spe

121 n antidiabetic GLP-1 analogue that carries a long-chain fatty acid.

122 , suggesting that enhanced synthesis of very-long-chain fatty acid/trihydroxy LCB ceramides promotes

123 alls and found a reduction in the amounts of long-chain fatty acids (C18:0) in the atltpI-4 mutant.

124 e the importance of oxidation of blood-borne long-chain fatty acids (Fa) in the cardiomyocytes for co

125 Long-chain fatty acids (FAs) act centrally to decrease f

126 ontrol mice were supplemented with saturated long-chain fatty acids (LCFA).

127 ct in synthesis of unsaturated long and very long-chain fatty acids (LCFAs and VLCFAs) and depletion

128 Free fatty acid receptors (FFARs) for long-chain fatty acids (LCFAs) and SCFAs are expressed i

129 Long-chain fatty acids (LCFAs) are used as a rich source

130 ingolipids are synthesized de novo from very long-chain fatty acids (VLCFA) and sphingoid long-chain

131 ccumulation of peroxisomal educts (like very-long-chain fatty acids [VLCFAs] or branched-chain fatty

132 ent mitochondrial model of beta-oxidation of long-chain fatty acids and main energy-redox processes i

133 art and muscle reduced complete oxidation of long-chain fatty acids by 87 and 69%, respectively, with

134 is led to a significant increase in the very-long-chain fatty acids C24 and C26 in the cuticular wax

135 Previous research has indicated that long-chain fatty acids can bind myoglobin (Mb) in an oxy

136 ietary and bacteria-derived medium-chain and long-chain fatty acids exacerbate, whereas short-chain f

137 tabolomics analysis, we found an increase in long-chain fatty acids in BMPR2 mutant mouse RVs compare

138 Cs and sterols and suggested a role for very-long-chain fatty acids in the interdigitation between th

139 ACAD9 also retains enzyme ACAD activity for long-chain fatty acids in vitro, but the biological rele

140 mportation of docosohexaenoic acid and other long-chain fatty acids into fetal and adult brain and is

141 tions in ABCD1 lead to incorporation of very-long-chain fatty acids into phospholipids, we separately

142 e the transfer of long-chain as well as very-long-chain fatty acids into the apoplast, depending on t

143 without fatty acids, but in the presence of long-chain fatty acids is "switched on" as a proton tran

144 mation, whereas supplementation with omega 3 long-chain fatty acids protect against intestinal inflam

145 esting essentiality may be linked to feeding long-chain fatty acids to FAS-II.

146 d bioactive molecules that include amides of long-chain fatty acids with taurine [N-acyl-taurines (NA

147 oline species containing polyunsaturated and long-chain fatty acids, indicating the presence of matur

148 noleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incide

149 he upper surface of the petal is enriched in long-chain fatty acids, which are constituents of the wa

150 hat transports LPCs containing DHA and other long-chain fatty acids.

151 ed that AtLtpI-4 protein can bind these very-long-chain fatty acids.

152 tabolism and vacuolar morphology through the long-chain fatty acyl-CoA synthetase Faa1, independently

153 ember 2 (Them2) is a mitochondria-associated long-chain fatty acyl-CoA thioesterase that is activated

154 requires strict control of the metabolism of long-chain fatty acyl-CoAs because of the multiplicity o

155 of class II ceramide synthases that use very-long-chain fatty acyl-coenzyme A and trihydroxy LCB subs

156 hyde-deformylating oxygenase (cADO) converts long-chain fatty aldehydes to alkanes via a proposed dif

157 d is suitable for the analysis of medium and long chain FFAs in beer.

158 Saturated long chain FFAs induced apoptosis and JNK activation in

159 ous AFFF components and enhanced sorption of long-chain fluorotelomer betaines.

160 though AH-7614 did not antagonize the second long-chain free fatty acid receptor, free fatty acid rec

161 It is established that long-chain free fatty acids includingomega-3 fatty acids

162 monoacylglycerol, glycerol, and medium- and long-chain free fatty acids, reflective of lipid mobiliz

163 pounds of low volatility, such as medium and long-chain free fatty acids, whereas compounds with high

164 ed in photoreceptor cells and generates very long chain (>/=C28) polyunsaturated fatty acids includin

165 In this contribution, the synthesis of long chain hexatriynyl- and octatetraynyl-substituted py

166 al isolates also displayed strong binding to long-chain "human-like" alpha2,6-linked sialic acids and

167 Our data reveal that long chain hydrocarbon-dominated organic matter (types I

168 rogenation of carbon monoxide (CO), produces long chain hydrocarbons and offers an alternative to the

169 ecific nature of the interaction between the long-chain hydrocarbons and the hydrophobic amino acids.

170 While traditionally mainly methanol and long-chain hydrocarbons are produced by CO hydrogenation

171 A two-state mathematical model for long-chain hydrocarbons which have multi-structural spec

172 ates for the cleavage of C-C single bonds in long-chain hydrocarbons, we analyzed protein structures

173 The long-chain ILs were significantly more toxic than the sh

174 suggest that 1-deoxysphingolipids, the very-long-chain in particular, play a role as molecular inter

175 formed between charged micelles (i.e., from long chain ionic surfactants) and neutral cyclodextrins

176 dicated that the cardioprotective effects of long-chain (LC) n-3 (omega-3) polyunsaturated fatty acid

177 about the metabolic fate of the intermediary long-chain (LC) n-3 polyunsaturated fatty acid (PUFA) do

178 Dietary long-chain (LC) omega-3 polyunsaturated fatty acids (PUF

179 re typically coated with a layer of short or long-chain ligands.

180 selectivities for the biphasic production of long-chain linear aldehydes under benign aqueous conditi

181 lipid order, indicating that segregation of long-chain lipids into myelin sheets is a process specif

182 Serum levels of selected long-chain lysoPCs are promising markers for the progres

183 Progressively lower levels of long-chain lysophosphatidylcholines (lysoPC a C18:2, lys

184 But, synthesis of long-chain macromolecules needed to support higher-order

185 come knotted, from macroscopic twine down to long-chain macromolecules such as DNA.

186 ses influences the global properties of very-long-chain molecules.

187 and knotted, from macroscopic string down to long-chain molecules.

188 A comprehensive account is given of long-chain monomer syntheses and the preparation and phy

189 The availability of long-chain monomers as a key prerequisite has benefited

190 of gamma-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained

191 nd they provide a foundation for engineering long-chain monounsaturated oils in other species.

192 lled as organic is not a guarantee of higher long chain n-3 fatty acids.

193 Dietary fish oils, rich in long-chain n-3 (omega-3) fatty acids (FAs) [e.g., docosa

194 Adding long-chain n-3 (omega-3) polyunsaturated fatty acids (PU

195 Proportions of n-3 PUFAs (very long-chain n-3 [VLC n-3; sum of eicosapentaenoic acid, d

196 Maternal supplementation with long-chain n-3 polyunsaturated fatty acids can have immu

197 ermine whether supplementation with 2.7 g of long-chain n-3 polyunsaturated fatty acids in pregnancy

198 Regular intake of oily fish and higher long-chain n-3 PUFA intake were associated with a reduce

199 owing FA intervention, a reduction in plasma long-chain n-3 PUFA was associated with a reduction in a

200 dietary intake and adipose tissue content of long-chain n-3 PUFAs and subsequent 5-y change in body w

201 Dietary intake and adipose tissue content of long-chain n-3 PUFAs were neither consistently nor appre

202 In EPIC-InterAct, among long-chain n-3 PUFAs, alpha-linolenic acid (ALA) was inv

203 Serum linoleic acid and very-long-chain n-3 PUFAs, partly reflecting vegetable oil an

204 0.30-0.67] for highest vs lowest tertile of long-chain n-3 PUFAs; P trend < .001).

205 gher proportions of certain VLC n-3 and very long-chain n-6 PUFAs in plasma phospholipids at age 8 ye

206 at the same reaction can be tuned to produce long-chain n-aldehydes, 1-alcohols and olefins, as well

207 hanogenic consortium capable of mineralizing long-chain n-paraffins (C28 -C50 ) was enriched from San

208 he very short synthesis of highly stereopure long-chain natural products containing remote, methyl-be

209 Long-chain ocean-transported PFCAs increased 2-4% per ye

210 butyl) rather than the ones with medium and long chains (octyl, dodecyl, hexadecyl and eicosyl).

211 The number of long chains of amylopectin was reduced and short chains

212 o distinct forms of soft matter, composed of long chains of covalently and noncovalently linked struc

213 cturally extremely simple, polyP consists of long chains of covalently linked inorganic phosphate gro

214 ylogenetically diverse microbes that produce long chain, olefinic hydrocarbons have received much att

215 id product and initiates the biosynthesis of long chain olefins in bacteria.

216 This new microalga can be cultivated for long chain omega-3 fatty acids and lutein production in

217 Demand for long chain omega-3 fatty acids from non-fish source for

218 GASE1 is required for the production of very long chain omega-7s in the aleurone.

219 Long-chain omega-3 (n-3) polyunsaturated fatty acids (LC

220 To assess the efficacy of 2 forms of oral long-chain omega-3 (omega-3) essential fatty acid (EFA)

221 A moderate daily dose of both forms of long-chain omega-3 EFAs, for 3 months, resulted in reduc

222 The long-chain omega-3 fatty acids (n-3 FAs) docosahexaenoic

223 ion.We tested the effects of high-dose, very-long-chain omega-3 fatty acids on adipose tissue inflamm

224 ontain a rich source of the health promoting long-chain omega-3 fatty acids, eicosapentaenoic (EPA) a

225 ffer in fatty acid composition, specifically long-chain omega-3 polyunsaturated fatty acid (LCPUFA) c

226 The retina is rich in long-chain omega-3 polyunsaturated fatty acids (LComega3

227 or psychosis is dietary supplementation with long-chain omega-3 polyunsaturated fatty acids (PUFAs).

228 This effect might be caused by long-chain-oxidized-products of BCC.

229 carbon or distance from upstream sources for long-chain perfluoroalkyl acids.

230 ed fraction was almost consistently >50% for long-chain perfluoroalkyl carboxylates and sulfonates (>

231 Concentrations of PFUnDA, representing long-chain perfluoroalkyl carboxylic acids (PFCAs), show

232 Long-chained perfluoroalkyl carboxylates (PFCAs) in arct

233 atively low drinking water concentrations of long-chain PFAAs substantially increase human body burde

234 ASs were detected, Asian countries still use long chain PFASs.

235 online SPE-HPLC-MS/MS was used to measure 10 long-chain PFASs in serum from blood collected cross-sec

236 on a limited selection of rather well-known long-chain PFASs, particularly perfluorooctanesulfonate

237 nclude perfluorooctanoic acid (PFOA; C8) and long-chain PFCAs (C9-C20).

238 heir term infants, we measured PFOA and four long-chain PFCAs (ng/mL) in third-trimester maternal ser

239 Studies examining long-chain PFCAs and fetal and postnatal growth are limi

240 t atmospheric inputs (via precursors) of the long-chain PFCAs are important contributors in the study

241 Prenatal exposure to long-chain PFCAs may interfere with fetal and childhood

242 ted the associations of prenatal exposure to long-chain PFCAs with fetal and postnatal growth.

243 PFOS and long-chained PFCAs (C9-C13) increased significantly over

244 , due to increasing hydrophobicity, with the long-chain phosphonium ILs being toxic while the shorter

245 ents have revealed that mammals, fungal, and long-chain plant cis-PTs are heteromeric enzymes compose

246 s, mechanical behavior, and degradability of long-chain polyester, polyamides, polyurethanes, polyure

247 The design strategy is to anchor the long-chain polymer networks of tough hydrogels covalentl

248 les being delivered to a greater extent than long-chain polymers.

249 one-target and protein-lipid assemblies, and long-chain polymers.

250 arly stage accompanied by the dissolution of long-chain polysulfide, and solid-state transition from

251 eiving breast milk with higher levels of n-3 long chain polyunsaturated (LCP) fatty acids (OR 0.50; 9

252 Fish fed the CS diet had significantly more long chain polyunsaturated fatty acid than had those fed

253 nterest in the de novo production of omega-3 long chain polyunsaturated fatty acids such as eicosapen

254 in, targets liver cancer cells and increases long chain polyunsaturated fatty acids, but decreases ce

255 tent of unsaturated fatty acids and valuable Long Chain Polyunsaturated fatty acids.

256 Biologically active long-chain polyunsaturated FAs (PUFAs; eicosapentaenoic

257 9-week experimental feeding period to reduce long-chain polyunsaturated fatty acid (LC-PUFA) and pers

258 The omega-3 (n-3) long-chain polyunsaturated fatty acid (LCPUFA) docosahex

259 othesized that the n-6:n-3 (omega-6:omega-3) long-chain polyunsaturated fatty acid (LCPUFA) ratio in

260 shed 15%-30% after adjustment for mercury or long-chain polyunsaturated fatty acid concentrations.

261 adjusted for umbilical cord blood mercury or long-chain polyunsaturated fatty acid concentrations.

262 sted that docosahexaenoic acid (DHA), an n-3 long-chain polyunsaturated fatty acid, might reduce the

263 ized in the stroma, then converted into very-long-chain polyunsaturated fatty acids (FAs) at the endo

264 strated to have the ability to biosynthesize long-chain polyunsaturated fatty acids (LC-PUFA) from C1

265 a daily intake of up to 500 mg omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA) is reco

266 The biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFA) provide

267 t increased maternal intake of omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFAs) during

268 ntal studies show that dietary omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFAs) reduce

269 Dietary omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs), docos

270 Long-chain polyunsaturated fatty acids (LCPUFAs) (1 g) a

271 Dietary and endogenously formed long-chain polyunsaturated fatty acids (LCPUFAs) are hyp

272 Reduced intake of n-3 long-chain polyunsaturated fatty acids (LCPUFAs) may be

273 Dietary omega-3 (n-3) long-chain polyunsaturated fatty acids (omega-3 LCPUFAs)

274 nt formulas in the United States contain the long-chain polyunsaturated fatty acids (PUFAs) docosahex

275 d perinatal periods, many nutrients, such as long-chain polyunsaturated fatty acids [contained in fis

276 l studies suggest that levels of n-3 and n-6 long-chain polyunsaturated fatty acids are associated wi

277 Metabolites of long-chain polyunsaturated fatty acids derived from the

278 are markedly enriched in omega-3 and omega-6 long-chain polyunsaturated fatty acids, which others hav

279 nprecedent in the synthesis of new, organic, long chain polyynes.

280 n of main group elements (groups 13-16) into long chains provides access to materials with fascinatin

281 Insects have very low long-chain PUFA concentrations, and the effect of omega-

282 n stunting and low serum omega-3 and omega-6 long-chain PUFAs, which are essential for growth and dev

283 y, gas phase enthalpies of formation of many long chain saturated and unsaturated fatty acids and of

284 hment in sterols and sphingolipids with very long chain saturated fatty acids when compared with the

285 Compounds based on long chain saturated fatty acids, i.e. palmitic, stearic

286 s show significantly greater accumulation of long-chain saturated ceramides that are substrate for AC

287 FAs and low n-6 (omega-6) FAs, 2) high very-long-chain saturated FAs, 3) high n-3 (omega-3) FAs, 4)

288 tearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations

289 geted lipidomics strategies, we identify two long-chain saturated NATs-N-tetracosanoyl-taurine [NAT(2

290 Both receptors bind medium- to long-chain, saturated and omega-3 unsaturated fatty acid

291 ally and classified into short-, medium-, or long-chain scores, in a case-cohort study within the Pre

292 are associated with diabetes; however, very-long-chain SFAs (VLSFAs), with 20 or more carbons, diffe

293 entrations of Tg and Tg analogs with various long-chain substitutions at the O-8 position extensively

294 multiple linear regression revealed that the long-chain-to-intermediate-chain acylcarnitine ratio inv

295 Long-chain-to-intermediate-chain acylcarnitine ratio, a

296 prene, E. ulmoides has evolved to synthesize long-chain trans-polyisoprene via farnesyl diphosphate s

297 Finally, we report that resting levels of long-chain triacylglycerols in mitochondrial myopathy co

298 h lower levels of mycolic acid wax ester and long-chain triacylglycerols than those for wild-type bac

299 Nanoemulsions prepared using long chain triglycerides (corn or fish oil) were most ef

300 data can be calculated by summing the innate long-chain vitamin A esters with the added esters.